Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
271 people get CRTX articles and Market Currents by email alert.
Get email alerts on CRTX »
FOCUS
|
PRO
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
To learn more about Seeking Alpha Pro, click here.
-
-
-
-
-
-
-
-
-
-
-
-
-
3 More Biotechs With FDA Decision Dates In Q4 2012David Zanoni • Thu, May 31, 2012 -
5 Cash Hoarding Small Cap Healthcare Stocks With Analyst LoveZetaKap • Mon, May 28, 2012
-
6 High-Growth Biotechnology Stocks With Great LiquidityZetaKap • Tue, May 15, 2012
-
-
-
10 Biotech Stocks Undervalued By Levered Free Cash FlowsKapitall • Wed, Dec 7, 2011 -
Progenics Pharmaceuticals JumpedM. E. Garza • Thu, Dec 1, 2011 -
12 Smart Money Biotech Picks Releasing Earnings Next WeekKapitall • Thu, Oct 27, 2011
-
Marketwire (May 9, 2013)
-
Marketwire (May 8, 2013)
-
Marketwire (May 2, 2013)
-
Marketwire (Mar 20, 2013)
-
Marketwire (Mar 14, 2013)
-
Marketwire (Mar 7, 2013)
-
Marketwire (Feb 25, 2013)
-
Marketwire (Feb 20, 2013)
-
Marketwire (Nov 8, 2012)
-
Marketwire (Nov 7, 2012)
-
Marketwire (Nov 1, 2012)
-
Marketwire (Nov 1, 2012)
-
Marketwire (Sep 13, 2012)
-
Marketwire (Aug 9, 2012)
-
Marketwire (Aug 2, 2012)
-
Marketwire (Jul 2, 2012)
CRTX vs. ETF Alternatives
Company Description
Currently, there's no company description for CRTX.
- All
- | Earnings
- | Dividends
- | M&A
- | On the move
-
Thursday, June 13, 12:45 PM
Midday top 10 gainers: BLC +27%. GCI +26%. CERE +19%. TVL +17%. LRAD +14%. GTN +13%. ENVI +13%. VSTM +12%. PXLW +12%. OVRL +11%.
Midday top 10 Losers: CHNG.PK -19%. HMTV -16%. EAC -15%. SGOC -14%. CREG -13%. CRTX -11%. RFIL -11%. VELT -10%. ECTE -10%. JVA -9%. 1 Comment [On the Move] - Thursday, June 13, 10:49 AM Cornerstone Therapeutics (CRTX -11.5%) plummets after saying it has received a letter from Exela Pharma regarding the filing of an NDA for a product similar to CRTX's CARDENE I.V. Premixed Injection. The company says it will "pursue all available legal and regulatory avenues in defense" of CARDENE. (PR) Comment! [Healthcare, On the Move]
- Thursday, May 9, 9:50 AM Cornerstone Therapeutics (CRTX): Q1 EPS of $0.24 beats by $0.11. Revenue of $38M beats by $2.57M. (PR) Comment! [Earnings, Breaking News, Healthcare]
- Thursday, March 21, 11:23 AM Cornerstone Therapeutics (CRTX -2.8%) says it's retained Lazard to act as its independent financial advisor and Clifford Chance to act as its independent legal counsel to assist the Special Committee in considering purchasing the company's common stock that it does not already own for a cash price of between $6.40 and $6.70 per share. Comment! [Healthcare, On the Move]
- Thursday, March 14, 7:22 AM Cornerstone Therapeutics (CRTX): Q4 EPS of -$0.26 misses by $0.36. Revenue of $34.9M misses by $1.1M. (PR) Comment! [Earnings, Breaking News, Healthcare]
-
Wednesday, February 20, 12:45 PM
Midday top 10 gainers: NVGN +46%. IMMY +33%. IKNX +29%. NTSP +29%. CRTX +22%. LZB +17%. CHLN +16%. RVLT +15%. CMGE +14%. TCX +14%.
Midday top 10 losers: HNR -39%. MM -36%. GMXR -19%. MEIL -19%. JAXB -18%. ANAD -16%. ODP -14%. ONCY -13%. BONE -13%. COBR -12%. Comment! [On the Move] - Tuesday, February 19, 5:35 PM Cornerstone Therapeutics (CRTX) +20% AH to $6.55 after disclosing Italy's Chiesi Therapeutics, which already owns 65% of Cornerstone, delivered a letter yesterday offering to buy the rest of it for $6.40-$6.70/share in cash. (13D) Comment! [Healthcare, On the Move, M&A]
- Thursday, November 8, 2012, 7:58 AM Cornerstone Therapeutics (CRTX): Q3 EPS of $0.19 misses by $0.13. Revenue of $37.5M (+49% Y/Y) beats by $5.5M. (PR) Comment! [Earnings, Healthcare]
- Thursday, September 13, 2012, 2:12 PM Cornerstone Therapeutics (CRTX -17%) shares plunge after an FDA advisory panel votes against approval of lixivaptan for the treatment of low sodium levels in the blood associated with heart failure. Shares resumed trading at 2:00 after a halt at the open. Comment! [Healthcare, On the Move]
- Tuesday, September 11, 2012, 9:36 AM FDA reviewer Nancy Xu says Cornerstone's (CRTX +5.3%) Lixivaptan drug should be approved to treat low sodium levels in the blood due to a condition that causes the body to have excess water. However, Xu says Lixivaptan shouldn't be authorized for heart-failure patients. An FDA advisory panel is due to meet on Thursday. Comment! [On the Move, Healthcare]
-
Tuesday, September 11, 2012, 9:10 AM
Premarket gainers: WSB +91%. SNSS +48%. CTIC +15%. NOK +7%. CRTX +7%. RBS +6%. PSTI +5%.
Losers: NAVB -31%. PPO -12%. PANW -8%. SQNM -7%. PPHM -6%. Comment! [On the Move] - Tuesday, March 13, 2012, 9:02 AM Cornerstone Therapeutics (CRTX) +9.3% premarket after announcing that the FDA has accepted a new drug application for CRTX 080, its product candidate for the treatment of hyponatremia. Comment! [Healthcare, On the Move]
-
- View all 2 replies
-
-
-
- View all 0 replies
-
- View all 0 replies
-
- View all 5 replies
-
robnjit: Scott. Agree. Wild ride. I had 10k worth of shares. Happy days when since you made the recommendation! -
reachmygoals1: scott, i added crtx today. it looks like high potential for a run with panel votes on thursday. company has lots of cash
-
Joe Springer
#biotech #pharma #stocks $VNDA $LLY $PPHM $GHDX $SCLN $AMRN $CRTX $NVS Vanda looks like a buy here: http://seekingalpha.com/a/h3pb - View all 0 replies
-
- View all 0 replies
-
Scott Matusow
$CRTX is my new catalyst pick. Article covering it tomorrow. @Sheffstation Likes this one. - View all 18 replies
-
-
-
- View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
LATEST REPLIES
-
- View all 2 replies
-
-
-
- View all 5 replies
-
robnjit: Scott. Agree. Wild ride. I had 10k worth of shares. Happy days when since you made the recommendation!
-
reachmygoals1: scott, i added crtx today. it looks like high potential for a run with panel votes on thursday. company has lots of cash
-
Scott Matusow
$CRTX is my new catalyst pick. Article covering it tomorrow. @Sheffstation Likes this one. - View all 18 replies
-
-